PuSH - Publikationsserver des Helmholtz Zentrums München

Dobiasch, S.* ; Goerig, N.L.* ; Fietkau, R.* ; Combs, S.E.

Essential role of radiation therapy for the treatment of pancreatic cancer.

Strahlenther. Onkol. 194, 185–195 (2018)
DOI Verlagsversion bestellen
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Pancreatic cancer is one of the most aggressive human tumors and the incidence has increased over the last 6 years. In the majority of cases the disease is already in an advanced stage at the time of diagnosis where surgery, the only curative treatment, is no longer an option and explains the still abysmal overall survival. The role of radiation therapy as treatment option for patients with pancreatic cancer is controversially discussed although radiation oncology has emerged as a central pillar in the combined oncological treatment. The present manuscript gives an overview of advanced radiotherapeutic strategies in the context of chemotherapy and surgery according to the current American Society of Clinical Oncology (ASCO) guidelines in comparison with the German guidelines and to elucidate the role of radiation therapy for the treatment of pancreatic cancer. Advanced modern radiotherapeutic techniques in combination with individualized high-precision radiation concepts are new therapeutic approaches for pancreatic cancer in a multimodal setting with tolerable side effects. Several clinical studies together with experimental approaches are in process, to deliver further evidence and ultimately allow true personalized medicine.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Intensity Modulated Radiotherapy ; Disease-free Survival ; Stereotactic Radiosurgery ; Clinical Studies ; Interdisciplinary Treatment; Stereotactic Body Radiotherapy; Gemcitabine-based Chemoradiation; Clinical-practice Guideline; Phase-iii Trial; Neoadjuvant Chemoradiation; Intraoperative Radiotherapy; Resectable Adenocarcinoma; Preoperative Gemcitabine; Retrospective Analysis; Adjuvant Radiotherapy
ISSN (print) / ISBN 0179-7158
e-ISSN 1439-099X
Quellenangaben Band: 194, Heft: 3, Seiten: 185–195 Artikelnummer: , Supplement: ,
Verlag Urban & Vogel
Verlagsort Heidelberg
Begutachtungsstatus Peer reviewed